ライフサイエンスコーパス: carotid stenosis

1 he example of endarterectomy for symptomatic carotid stenosis.

2 subjects with recently symptomatic > or =50% carotid stenosis.

3 pert population-based dietary guidelines and carotid stenosis.

4 and asymptomatic patients with extracranial carotid stenosis.

5 patients with recently symptomatic internal carotid stenosis.

6 elies on the detection of significant (>70%) carotid stenosis.

7 ascular treatment for symptomatic high-grade carotid stenosis.

8 sion, and to a lesser extent in asymptomatic carotid stenosis.

9 carotid endarterectomy for the treatment of carotid stenosis.

10 om 3007 patients with a recently symptomatic carotid stenosis.

11 can result in inaccuracies in assessment of carotid stenosis.

12 n (CSTC) involving patients with symptomatic carotid stenosis.

13 in patients with recently symptomatic 70-99% carotid stenosis.

14 and cigarette smoking with the prevalence of carotid stenosis.

15 ardiovascular risk factors and the degree of carotid stenosis.

16 artery, three of them also had contralateral carotid stenosis.

17 erectomy remains the treatment of choice for carotid stenosis.

18 reduces the risk of stroke in patients with carotid stenosis.

19 tenting with endarterectomy in patients with carotid stenosis.

20 time following TIA or stroke associated with carotid stenosis.

21 ombotic biomarker profile in moderate-severe carotid stenosis.

22 stenting and endarterectomy for symptomatic carotid stenosis.

23 ue vulnerability in patients with high-grade carotid stenosis.

24 l ischemic events, and stroke in symptomatic carotid stenosis.

25 unstable plaques in patients with high-grade carotid stenosis.

26 vide guidelines for management of women with carotid stenosis.

27 darterectomy for symptomatic or asymptomatic carotid stenosis.

28 waveform amplitudes were lowest with common carotid stenosis.

29 arotid branch ligation and by 80% via common carotid stenosis.

30 ct stroke risk in patients with asymptomatic carotid stenosis.

31 n the risk stratification of atherosclerotic carotid stenosis.

32 of management of patients with asymptomatic carotid stenosis.

33 ion system in high-risk patients with severe carotid stenosis.

34 d artery revascularization (70% asymptomatic carotid stenosis), 1025 (30%) with CAS and 2387 (70%) wi

35 t emergent and ipsilateral to the qualifying carotid stenosis; 2 additional ipsilateral TIAs occurred

36 igned in CAVATAS and completed treatment for carotid stenosis (200 patients had endovascular treatmen

37 ial for patients with asymptomatic > or =60% carotid stenosis (ACS), several other studies have repor

38 Carotid stenosis, an indicator of subclinical atheroscle

39 mulate hypothetical cohorts of patients with carotid stenosis and calculated quality-adjusted life ex

40 icenter registry of 419 patients with severe carotid stenosis and high-risk features for carotid enda

41 For some patients with severe carotid stenosis and high-risk features for carotid enda

42 ted with symptomatic status in patients with carotid stenosis and occlusion, but there is relatively

43 psilateral carotid arteries of patients with carotid stenosis and recent cerebral ischemic events.

44 ious studies suggest that some patients with carotid stenosis and serious comorbid conditions are at

45 ormulated regarding the relationship between carotid stenosis and vascular cognitive impairment.

46 ts 79 years of age or younger who had severe carotid stenosis and were asymptomatic (i.e., had not ha

47 nd peripheral arterial disease, asymptomatic carotid stenosis, and 10-year risk of acute coronary eve

48 d duration of filter deployment, symptomatic carotid stenosis, and baseline renal insufficiency.

49 of the brain parenchyma and of the degree of carotid stenosis, and charted test results (such as elec

50 Age, significant contralateral carotid stenosis, and complex aortic arch type were pred

51 carotid branches, creating an outflow common carotid stenosis, and constructing a midgraft stenosis.

52 with recently symptomatic than asymptomatic carotid stenosis, and decreases over time following TIA

53 Older age, symptomatic carotid stenosis, and nonelective hospital admission wer

54 d, are frequent in patients with symptomatic carotid stenosis, and predict recurrent stroke risk.

55 l arterial disease, coronary artery disease, carotid stenosis, and recurrent surgery and a higher log

56 utility of abnormal diffusion-weighted MRI, carotid stenosis, and transient ischaemic attack within

57 Patients with asymptomatic carotid stenosis are at increased vascular risk but opti

58 Many patients with asymptomatic carotid stenosis are offered carotid stenting for the pr

59 medical therapy for adults with asymptomatic carotid stenosis, as well as single-group prospective co

60 ring system on 990 ECST patients with 70-99% carotid stenosis assigned surgery (594) or medical treat

61 In the men, the odds ratio for moderate carotid stenosis associated with an increase of 20 mm Hg

62 d deviation] +/- 10.5; 75% men) with 16%-79% carotid stenosis at duplex ultrasonography were imaged w

63 clinical interest in patients with unstable carotid stenosis at risk of stroke.

64 or ischemic stroke: 18 patients with culprit carotid stenosis awaiting carotid endarterectomy and 8 c

65 ifferent control groups: 16 patients without carotid stenosis before and after diagnostic cerebral an

66 rterectomy depends not only on the degree of carotid stenosis, but also on several other clinical cha

67 tive to endarterectomy for the management of carotid stenosis, but its long-term safety and efficacy

68 nt to carotid endarterectomy for symptomatic carotid stenosis, but previous trials have not establish

69 is replacing intra-arterial angiography for carotid stenosis, but the accuracy remains uncertain des

70 cross subgroups defined by sex and degree of carotid stenosis, but there was a nonsignificant trend s

71 pirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) is a randomized, double-blind

72 appropriately selected patients with severe carotid stenosis, carotid revascularization reduces isch

73 relative risk of stroke was increased in all carotid stenosis categories but was most elevated in the

74 In patients with recently symptomatic carotid stenosis, combination therapy with clopidogrel a

75 likely to undergo procedural management for carotid stenosis compared with those in the salary-based

76 my by screening asymptomatic populations for carotid stenosis costs more per quality-adjusted life-ye

77 erectomy (CEA) for patients with symptomatic carotid stenosis (CS).

78 nued embolization is common in patients with carotid stenosis despite aspirin therapy.

79 CDI was assessed for internal carotid stenosis, diabetic retinopathy, glaucoma, and br

80 emains the standard of care for extracranial carotid stenosis except in specific clinical scenarios.

81 ons include staged operations addressing the carotid stenosis first, reverse staged operations addres

82 ts who underwent CEA for severe asymptomatic carotid stenosis from 1989 to 2005 were identified.

83 26 patients with symptomatic or asymptomatic carotid stenosis from 95 centres in 24 countries.

84 The creation of an outflow common carotid stenosis generates clinically relevant (poor run

85 oronary and carotid disease with significant carotid stenosis greater than 70% in approximately 8% of

86 hed treatments for patients with symptomatic carotid stenosis >/=70%.

87 Forty-seven patients with carotid stenosis >40% on duplex ultrasonography and who

88 terectomy (CEA) in patients with symptomatic carotid stenosis >70% by a randomized, controlled trial

89 cations for CAS or CEA included asymptomatic carotid stenosis >70% or symptomatic stenosis >50%.

90 ; 76.7% were asymptomatic with flow-limiting carotid stenosis >80%.

91 If ultrasonography found significant carotid stenosis (> or = 60%), disease was confirmed by

92 Moderate carotid stenosis (> or =25 percent) was present in 189 m

93 s were significantly higher in patients with carotid stenosis (>/= 70%) compared to controls, with no

94 k (TIA), or retinal embolism and ipsilateral carotid stenosis (>/=50%) were included.

95 ignals (MES) in asymptomatic and symptomatic carotid stenosis has not been comprehensively assessed.

96 EA as the preferred treatment of symptomatic carotid stenosis if a reduction in costs can be achieved

97 s, indications for surgery were asymptomatic carotid stenosis in 167 (24.6%), transient ischemic atta

98 (11.5%) patients with > or = 50% ipsilateral carotid stenosis in 357/387 (92%) patients with carotid

99 evidence as the standard treatment of severe carotid stenosis in both symptomatic and asymptomatic pa

100 dical management in the management of severe carotid stenosis in both symptomatic and asymptomatic pa

101 is greater than the prevalence of > or = 50% carotid stenosis in carotid territory events, and is ass

102 ressure showed significant associations with carotid stenosis in men and insignificant associations i

103 th intra-arterial angiography for diagnosing carotid stenosis in patients with carotid territory isch

104 Synchronous carotid stenosis in patients with coronary artery diseas

105 ed with those from patients with symptomatic carotid stenosis in the early (</= 4 weeks) and late pha

106 stic models from data on patients with 0-69% carotid stenosis in the European Carotid Surgery Trial (

107 ng were associated with an increased risk of carotid stenosis in this elderly population.

108 The management of carotid stenosis in women remains a topic of controversy

109 In recently symptomatic carotid stenosis, inflammation-related FDG uptake was as

110 ive intensification, antihypertensive class, carotid stenosis intervention, and substance abuse refer

111 Symptomatic carotid stenosis is associated with a 3-fold risk of ear

112 is beneficial for patients with asymptomatic carotid stenosis is controversial.

113 e stroke with unilateral asymptomatic 70-99% carotid stenosis is likely small based on several observ

114 benefit from endarterectomy for asymptomatic carotid stenosis is small, but can sometimes be justifie

115 Inaccuracy in the measurement of carotid stenosis may contribute to conflicting estimates

116 ny patients with recently symptomatic 70-99% carotid stenosis may not benefit from carotid endarterec

117 patients had correction of a severe internal carotid stenosis (mean 95.6 +/- 3.7%) with a concurrent

118 r carotid occlusion (n = 48) or asymptomatic carotid stenosis (n = 59).

119 Successful CS for severe carotid stenosis/occlusion improves NCF, but only in pat

120 r a history of clinical disease, an internal carotid stenosis of > or = 40% by duplex scan, or an ank

121 se vitamins were 2.5 times as likely to have carotid stenosis of >30%.

122 as beneficial for symptom-free patients with carotid stenosis of 60% or more.

123 vational study in patients with asymptomatic carotid stenosis of at least 70% from 26 centres worldwi

124 risk, 47.4% were symptomatic, and 97.4% had carotid stenosis of at least 70%.

125 valence of > or = 50% apparently symptomatic carotid stenosis on ultrasound imaging in consecutive pa

126 Patients with carotid stenosis or occlusion may be at increased risk f

127 ck (OR 3.3, 95% CI 1.8-5.8), and ipsilateral carotid stenosis (OR 4.7, 95% CI 2.6-8.6) were associate

128 nd in the carotid occlusion (P: = 0.019) and carotid stenosis (P: = 0.015) groups alone.

129 e was enriched to patients with asymptomatic carotid stenosis (P=0.038).

130 Symptomatic carotid stenosis patients are at high risk of early recu

131 s carotid revascularization for asymptomatic carotid stenosis, require reassessment given advances in

132 One patient developed carotid stenosis requiring surgery.

133 which emerging catheter-based therapies for carotid stenosis should be compared.

134 screening to identify cases of asymptomatic carotid stenosis should be implemented.

135 ardiac surgery include giant cell arteritis, carotid stenosis, stroke, hypercoagulable state, and DM

136 Carotid stenosis, symptomatic and asymptomatic, is preva

137 atients with concomitant aortic atheroma and carotid stenosis that may predispose to stroke in the pe

138 ng patients with symptomatic or asymptomatic carotid stenosis, the risk of the composite primary outc

139 ed patients with symptomatic or asymptomatic carotid stenosis to undergo carotid-artery stenting or c

140 need to evaluate real-world effectiveness of carotid stenosis treatments.

141 four randomised controlled trials within the Carotid Stenosis Trialists' Collaboration (CSTC) involvi

142 METHODS AND Thirty patients with severe carotid stenosis underwent (18)F-fluorodeoxyglucose-posi

143 Forty-five patients with 30%-99% carotid stenosis underwent dynamic contrast-enhanced MR

144 ptomatic population with a 40% prevalence of carotid stenosis was found).

145 The risk of carotid stenosis was greater for people who had weighed

146 Angioplasty Study (CAVATAS), early recurrent carotid stenosis was more common in patients assigned to

147 risk factors and, in contrast to > or = 50% carotid stenosis was not associated with evidence of cor

148 ral and contralateral angiographic degree of carotid stenosis was recorded at the time of the operati

149 th moderate or severe (>/= 50%) asymptomatic carotid stenosis were compared with those from patients

150 Forty-two patients with >70% carotid stenosis were enrolled.

151 enting Study), 231 patients with symptomatic carotid stenosis were randomized to undergo CAS (n=124)

152 Patients with symptomatic carotid stenosis were randomly assigned 1:1 to open trea

153 ndred and six patients with mild to moderate carotid stenosis were recruited in this study (53 sympto

154 with cerebrovascular ischemia ipsilateral to carotid stenosis were selected randomly for CEA or carot

155 ng embolization in patients with symptomatic carotid stenosis who already were taking aspirin.

156 used to identify patients with asymptomatic carotid stenosis who are at a higher risk of stroke and

157 fining particular subgroups of patients with carotid stenosis who are at higher risk of stroke who mi

158 the selection of patients with asymptomatic carotid stenosis who are likely to benefit from endarter

159 tool to identify asymptomatic patients with carotid stenosis who are most likely to benefit from rev

160 involving asymptomatic patients with severe carotid stenosis who were not at high risk for surgical

161 nd development of percutaneous treatment for carotid stenosis will provide neurovascular anesthesiolo

162 Ys) and costs for asymptomatic patients with carotid stenosis with 70%-89% carotid luminal narrowing

163 ion between IgA seropositivity and >50% mean carotid stenosis with an odds ratio of 5.24 (95% CI 1.24

164 id stenting is equivalent to CEA in reducing carotid stenosis without increased risk for major compli

165 leading approaches to revascularization for carotid stenosis, yet contemporary data on trends in rat